Skip to content

Clinical trials

Myocardial Ischemia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Ischemia Country / region: United States Clear all

215 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20015
20022
20033
200410
20058
20067
20078
200820
200910
201014
20116
201210
201310
201410
20156
20168
20177
20188
20198
20206
20218
20223
20237
20246
20256
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed146
Terminated23
Recruiting20
Unknown status10
Withdrawn8
Enrolling by invitation4
Active, not recruiting3
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abbott Medical Devices18
National Heart, Lung, and Blood Institute (NHLBI)12
NYU Langone Health8
Mayo Clinic7
US Department of Veterans Affairs5
Johns Hopkins University4
University of California, San Francisco4
Cedars-Sinai Medical Center3
Duke University3
Genetesis Inc.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Ischemia215
Coronary Artery Disease89
Cardiovascular Diseases46
Heart Diseases45
Coronary Disease44
Myocardial Infarction35
Vascular Diseases26
Coronary Stenosis20
Angina Pectoris19
Arteriosclerosis18

Trials

Showing 26 to 50 of 215. Each trial links to its page on Pharma Observatory.

115 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.